Chanelle Pharma announces Platinum Partnership with ISPCA

Chanelle Pharma announces Platinum Partnership with ISPCA 09th December 2024 – Chanelle Pharma has achieved Platinum Status in the ISPCA Corporate Membership Circle. This status demonstrates our commitment to animal welfare and making a significant impact in the lives of countless animals in need. Chanelle and the ISPCA share a deep commitment to compassion, animal welfare, and community support. Through our partnership, […]

Chanelle Pharma appoints Angelo Gatto to drive growth and expansion

Chanelle Pharma appoints Angelo Gatto to drive growth and expansion 1st August 2024, DUBLIN – Chanelle Pharma, Ireland’s largest manufacturer of generic pharmaceuticals for human and animal health, today announces the appointment of Angelo Gatto as CEO. Angelo brings 25 years of international experience in pharmaceuticals, in a career spanning animal health, human health and CDMO. He has held operational, commercial […]

Chanelle Pharma, Ireland’s largest indigenous manufacturer of generic pharmaceuticals acquired by Exponent

Chanelle Pharma,  Ireland’s largest indigenous manufacturer of generic pharmaceuticals acquired by Exponent One of Ireland’s most successful companies, Chanelle Pharma has been sold by its founder Michael H Burke to Exponent, a leading private equity firm.  Headquartered in Loughrea, Co. Galway, Chanelle Pharma is Ireland’s largest indigenous manufacturer of generic pharmaceuticals for animal and human health.  […]